logo-loader
NASDAQ:ADVM

Adverum Biotechnlogies Inc

Receive alerts
Market:
NASDAQ
Market Cap:
$405.45 m
Price
$6.29
Change
8.82%
52 weeks high
16.38
52 weeks low
2.62

In brief

Adverum Biotechnologies Inc (ADVM) is a clinical-stage gene therapy company targeting unmet medical needs in ophthalmology and rare diseases.